title: Experimental osteomyelitis: what have we learned from animal studies about the systemic treatment of osteomyelitis?
abstract: Clinical trials of systemic antibiotic treatment of osteomyelitis are difficult to perform for many reasons, such as low incidence rate of osteomyelitis, variety of anatomic locations, stage and etiologic agents. In this article, we reviewed the experimental studies on osteomyelitis available in the English medical literature since 1968, to ascertain their actual and potential impact on the treatment of human osteomyelitis. Major results are summarized and topics of major interest, such as reproducibility of animal models, predictive value of animal models, correlation of pharmacokinetics between different animals and humans, and the correlation of outcome between animal and clinical studies are discussed. Most of the reviewed animal models are reproducible and dependable. However, establishing the right dose regimen in animals appeared a critical factor, which might undermine the predictive value of the experimental study. Due to difficulties in comparing results of animal and human studies, the predictive value of animal studies about osteomyelitis is still unclear. However, animal models gave valuable information to the clinician for choosing the minimal duration of antibiotic treatment. Even though the use of antibiotic combinations was associated with better outcome in the majority of animal studies, such a finding seems to have limited impact on clinical practice.
authors.affiliation: Department of Infectious Diseases, S. Bortolo Hospital, Vicenza, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Lazzarini
authors.forename: K A
authors.initials: KA
authors.lastname: Overgaard
authors.forename: E
authors.initials: E
authors.lastname: Conti
authors.forename: M E
authors.initials: ME
authors.lastname: Shirtliff
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006801:Humans; D010019:Osteomyelitis / Q000188:drug therapy*; D011237:Predictive Value of Tests; D011817:Rabbits; D051381:Rats; D015203:Reproducibility of Results; D013203:Staphylococcal Infections / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents